Hence, the overlap between TDP-43 and tau pathologies in ALS [36] and FTLD [6], and the more marked tau pathology in patients with MND with, rather than without, cognitive impairment [36], could be interpreted as supporting the spectrum/continuum notion of the relationship between ALS and bvFTD. This evidence concerns the gene MAPT and mild neurocognitive disorder.